News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,114 Results
Type
Article (13579)
Company Profile (110)
Press Release (247425)
Section
Business (87948)
Career Advice (461)
Deals (15340)
Drug Delivery (64)
Drug Development (36525)
Employer Resources (49)
FDA (6259)
Job Trends (6186)
News (150041)
Policy (14006)
Tag
Academia (435)
Alliances (23084)
Alzheimer's disease (350)
Approvals (6251)
Artificial intelligence (60)
Bankruptcy (143)
Best Places to Work (4323)
Biotechnology (44)
Breast cancer (42)
Cancer (302)
Career advice (405)
Cell therapy (42)
Clinical research (30367)
Collaboration (143)
Compensation (58)
COVID-19 (747)
C-suite (50)
Data (319)
Diabetes (53)
Diagnostics (1240)
Drug pricing (57)
Earnings (31551)
Employer resources (43)
Events (36710)
Executive appointments (159)
FDA (6433)
Funding (99)
Gene therapy (59)
GLP-1 (291)
Government (1265)
Healthcare (3520)
Infectious disease (764)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5829)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3410)
Lung cancer (46)
Manufacturing (94)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9543)
Metabolic disorders (163)
Neuroscience (444)
NextGen Class of 2024 (1580)
Non-profit (589)
Northern California (419)
Obesity (98)
Opinion (109)
Patents (51)
People (28431)
Pharmaceutical (64)
Phase I (7896)
Phase II (12841)
Phase III (11540)
Pipeline (180)
Podcasts (39)
Policy (44)
Postmarket research (1399)
Preclinical (3164)
Radiopharmaceuticals (116)
Rare diseases (86)
Real estate (2629)
Regulatory (9812)
Research institute (562)
Resumes & cover letters (55)
Southern California (430)
Startups (1624)
United States (4150)
Vaccines (112)
Weight loss (77)
Date
Last 7 days (326)
Last 30 days (1147)
Last 365 days (12655)
2024 (11435)
2023 (14260)
2022 (19562)
2021 (20068)
2020 (19034)
2019 (14887)
2018 (11713)
2017 (13891)
2016 (13129)
2015 (15473)
2014 (12419)
2013 (10594)
2012 (11397)
2011 (11924)
2010 (10889)
Location
Africa (312)
Arizona (40)
Asia (19775)
Australia (2557)
California (979)
Canada (582)
China (108)
Colorado (40)
Connecticut (40)
Europe (38754)
Florida (141)
Illinois (111)
Indiana (83)
Kansas (51)
Maryland (153)
Massachusetts (858)
Minnesota (56)
New Jersey (410)
New York (268)
North Carolina (275)
Northern California (419)
Pennsylvania (275)
South America (498)
Southern California (430)
Texas (131)
Virginia (39)
Washington State (70)
261,114 Results for "newbridge pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Policy
BeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
BeiGene and NewBridge Pharmaceuticals announced that BRUKINSA® has received approval from the Saudi Food and Drug Authority for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.
November 14, 2021
·
14 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Press Releases
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
November 7, 2024
·
1 min read
Deals
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
Melt Pharmaceuticals, Inc. today announced the completion of its Series B Preferred Stock financing of approximately $24 million from new and existing investors at a pre‑money valuation that increased nearly 150% from the pre-money valuation for Melt’s Series A Preferred Stock.
April 2, 2024
·
2 min read
Press Releases
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 6, 2024
·
20 min read
1 of 26,112
Next
